Call Today: 585-484-0058
Initiatives / Partnerships
ATVC is a venture building company focused on commercializing innovative research, leading to the development of high-value products for large-market opportunities. Our clinical strengths are in addressing cancer stem cells, hair, skin, bone and anti aging conditions. Our technology and manufacturing strengths are in minimally manipulated biologic products derived from Wharton's Jelly and Mesenchymal Stromal Cells.
We work with numerous collaborators to license advanced biotechnology patents, for clinical, manufacturing, regulatory, finance, development, engineering programs. We value our partnerships as they are the key for driving the products to the market through the commercialization pathway.
ATVC is purpose-built to partner with other companies for early stage and late-stage product development and commercialization. We look for licensing partners to complement our strengths.
RIT College of Engineering Technology
Joint creation of new technology entrepreneurship and commercialization education certificate program taught by ATVC staff, with training at ATVC's headquarters training center. Greg Evershed, Director, Applied Research and Corporate Engagement College of Applied Science and Technology at RIT is the CET- ATVC Advisor
Moving wound applications and Veterinarian care towards an innovative future. The advancement of animal health and care through research partnership.
Start-Up New York is a new initiative that is a collaboration with UoR to designate
Sanatela Medical Solutions as a
Start-Up New York company.
Start-Up New York
UNIVERSITY OF ROCHESTER:
WILMONT CANCER CENTER,
STEM CELL & REGENERATIVE MEDICINE INSTITUTE
University of Rochester is a patent holder for Wharton Jelly's technology methods for our which our early stage company has an exclusive world-wide license.
EMPIRE STATE DEVELOPMENT
Empire State is supporting the growth and development of biotechnology manufacturing with Start-Up New York. New York government economic program that establishes funds and designations for unique advanced manufacturing developments.
Kansas University is a patent holder for Wharton Jelly's technology methods for our which our early stage company has an exclusive world-wide license.